Sale!

HTRA2 Gene PARK13 Parkinson Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The HTRA2 Gene PARK13 Parkinson Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the HTRA2 gene, which have been associated with the development of Parkinson’s disease. This test is particularly significant for individuals with a family history of Parkinson’s disease or those exhibiting early symptoms, as it provides crucial genetic information that can aid in the early diagnosis and management of this neurodegenerative disorder.

Parkinson’s disease is a progressive neurological condition characterized by tremors, stiffness, and difficulty with balance and coordination. The HTRA2 gene, also known as PARK13, plays a vital role in mitochondrial function and the regulation of cell death, with mutations in this gene linked to increased susceptibility to Parkinson’s disease. By analyzing the genetic makeup of the HTRA2 gene, the test can identify specific mutations that may increase an individual’s risk of developing Parkinson’s disease.

Conducted at the state-of-the-art facilities of DNA Labs UAE, the test is priced at 4400 AED. The process involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of mutations in the HTRA2 gene. Results from the test can provide valuable insights into an individual’s risk of developing Parkinson’s disease, enabling healthcare providers to tailor early intervention strategies and potentially improve patient outcomes.

The HTRA2 Gene PARK13 Parkinson Genetic Test is an important resource for individuals seeking to understand their genetic risk for Parkinson’s disease and for healthcare professionals aiming to provide targeted care for their patients.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

HTRA2 Gene PARK13 Parkinson Genetic Test

At DNA Labs UAE, we offer the HTRA2 Gene PARK13 Parkinson Genetic Test for individuals who suspect they may have Parkinson’s disease. This test can help diagnose and provide valuable information for personalized treatment options.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the HTRA2 Gene PARK13 Parkinson Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by HTRA2 Gene PARK13 Parkinson.

Test Details

The HTRA2 gene is associated with the PARK13 subtype of Parkinson’s disease. This rare form of Parkinson’s disease is caused by mutations in the HTRA2 gene. The NGS (Next-Generation Sequencing) genetic testing method is used to analyze multiple genes simultaneously, including the HTRA2 gene. This test can identify any genetic variants or mutations in the HTRA2 gene that may be linked to Parkinson’s disease.

It is important to note that genetic testing alone cannot definitively diagnose Parkinson’s disease, as it is a complex condition with multiple contributing factors. A healthcare professional should make a diagnosis based on clinical symptoms and other diagnostic tests. However, the information obtained from the HTRA2 Gene PARK13 Parkinson Genetic Test can be useful for diagnosis, prognosis, and potentially for personalized treatment options.

For more information or to schedule an appointment for the HTRA2 Gene PARK13 Parkinson Genetic Test, please contact our Genetics Test Department and consult with a Neurologist.

Test Name HTRA2 Gene PARK13 Parkinson Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for HTRA2 Gene PARK13 Parkinson NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with HTRA2 Gene PARK13 Parkinson
Test Details

The HTRA2 gene is associated with the PARK13 subtype of Parkinson’s disease. PARK13 is a rare form of Parkinson’s disease that is caused by mutations in the HTRA2 gene.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. It can identify mutations or variations in the HTRA2 gene that may be linked to Parkinson’s disease.

By performing an NGS genetic test on the HTRA2 gene, individuals can determine if they carry any genetic variants that are associated with PARK13 Parkinson’s disease. This information can be useful for diagnosis, prognosis, and potentially for personalized treatment options.

It is important to note that genetic testing alone cannot definitively diagnose Parkinson’s disease, as it is a complex condition with multiple contributing factors. A diagnosis should be made by a healthcare professional based on clinical symptoms and other diagnostic tests.